loadpatents
name:-0.077147960662842
name:-0.061043977737427
name:-0.0030319690704346
Goldstein; David Michael Patent Filings

Goldstein; David Michael

Patent Applications and Registrations

Patent applications and USPTO patent grants for Goldstein; David Michael.The latest application filed is for "immunoproteasome inhibitors".

Company Profile
2.55.60
  • Goldstein; David Michael - Redwood City CA
  • Goldstein; David Michael - San Jose CA US
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Immunoproteasome Inhibitors
App 20220073538 - Lou; Yan ;   et al.
2022-03-10
Immunoproteasome inhibitors
Grant 11,225,493 - Lou , et al. January 18, 2
2022-01-18
Immunoproteasome inhibitors
Grant 11,154,563 - Lou , et al. October 26, 2
2021-10-26
Immunoproteasome Inhibitors
App 20200277312 - Lou; Yan ;   et al.
2020-09-03
Immunoproteasome Inhibitors
App 20190336515 - Lou; Yan ;   et al.
2019-11-07
Substituted pyrrolo[2,3-b]pyrazines as JAK3 inhibitors
Grant 9,676,778 - Goldstein , et al. June 13, 2
2017-06-13
Pyrazolopyrimidine derivatives as tyrosine kinase inhibitors
Grant 9,376,438 - Goldstein , et al. June 28, 2
2016-06-28
Formulations Containing Reversible Covalent Compounds
App 20160045503 - Goldstein; David Michael ;   et al.
2016-02-18
Tyrosine Kinase Inhibitors
App 20150353562 - GOLDSTEIN; David Michael
2015-12-10
Tyrosine Kinase Inhibitors
App 20150353557 - Goldstein; David Michael ;   et al.
2015-12-10
Azaindole Derivatives As Jak3 Inhibitors
App 20150291600 - Goldstein; David Michael ;   et al.
2015-10-15
Tyrosine kinase inhibitors
Grant 9,090,621 - Goldstein July 28, 2
2015-07-28
Formulations Comprising Ibrutinib
App 20150140085 - Goldstein; David Michael
2015-05-21
Tyrosine kinase inhibitors
Grant 8,962,635 - Goldstein February 24, 2
2015-02-24
Tyrosine kinase inhibitors
Grant 8,962,831 - Goldstein February 24, 2
2015-02-24
Benzotriazole kinase modulators
Grant 8,962,622 - Goldstein , et al. February 24, 2
2015-02-24
Tyrosine kinase inhibitors
Grant 8,957,080 - Goldstein , et al. February 17, 2
2015-02-17
Tyrosine kinase inhibitors
Grant 8,946,241 - Goldstein February 3, 2
2015-02-03
Tyrosine Kinase Inhibitors
App 20140336382 - GOLDSTEIN; David Michael
2014-11-13
Kinase Inhibitors
App 20140323464 - Taunton, JR.; John William ;   et al.
2014-10-30
Tyrosine Kinase Inhibitors
App 20140309223 - GOLDSTEIN; David Michael
2014-10-16
Tyrosine Kinase Inhibitors
App 20140303161 - GOLDSTEIN; David Michael ;   et al.
2014-10-09
Tyrosine Kinase Inhibitors
App 20140303190 - GOLDSTEIN; David Michael
2014-10-09
Pyrazolopyrimidine Derivatives As Tyrosine Kinase Inhibitors
App 20140221398 - Goldstein; David Michael ;   et al.
2014-08-07
Tyrosine kinase inhibitors
Grant 8,759,358 - Goldstein June 24, 2
2014-06-24
Tyrosine Kinase Inhibitors
App 20140107151 - Goldstein; David Michael ;   et al.
2014-04-17
Tyrosine Kinase Inhibitors
App 20140094459 - Goldstein; David Michael ;   et al.
2014-04-03
Tyrosine kinase inhibitors
Grant 8,673,925 - Goldstein March 18, 2
2014-03-18
Azaindole Derivatives As Tyrosine Kinase Inhibitors
App 20140073626 - Goldstein; David Michael ;   et al.
2014-03-13
Inhibitors of JNK
Grant 8,642,601 - Arzeno , et al. February 4, 2
2014-02-04
JNK modulators
Grant 8,399,462 - Dunn , et al. March 19, 2
2013-03-19
Pyrimidinyl pyridone inhibitors of kinases
Grant 8,268,840 - Brookfield , et al. September 18, 2
2012-09-18
Inhibitors of JNK
Grant 8,183,254 - Arzeno , et al. May 22, 2
2012-05-22
Dihydroquinone and dihydronaphthridine inhibitors of JNK
Grant 8,163,906 - Abbot , et al. April 24, 2
2012-04-24
Inhibitors of JNK
App 20110301171 - Arzeno; Humberto Bartolome ;   et al.
2011-12-08
Hydroxyalkyl substituted pyrido-7-pyrimidin-7-ones
Grant 7,750,016 - Goldstein July 6, 2
2010-07-06
Inhibitors of JNK
App 20090318484 - Arzeno; Humberto Bartolome ;   et al.
2009-12-24
Pyrimidinyl pyridone inhibitors of kinases
App 20090270389 - Brookfield; Frederick ;   et al.
2009-10-29
Prediction of bone marrow toxicity
App 20090208991 - Ludwig Bitter; Hans Marcus ;   et al.
2009-08-20
Substituted pyrazolo{3,4-D}pyrimidines as p38 map kinase inhibitors
Grant 7,566,708 - Arora , et al. July 28, 2
2009-07-28
Prediction Of Genotoxicity
App 20090181415 - Bitter; Hans Marcus Ludwig ;   et al.
2009-07-16
Methods of inhibiting BTK and SYK protein kinases
Grant 7,501,410 - Goldstein , et al. March 10, 2
2009-03-10
Indazole derivatives and methods for using the same
Grant 7,495,015 - Arora , et al. February 24, 2
2009-02-24
Substituted quinazoline compounds useful as p38 kinase inhibitors
Grant 7,456,185 - Dunn , et al. November 25, 2
2008-11-25
Dihydroquinone and dihydronaphthridine inhibitors of JNK
App 20080287458 - Abbot; Sarah C. ;   et al.
2008-11-20
Substituted pyrazolo [3,4-d] pyrimidines and methods of using the same
Grant 7,452,880 - Arora , et al. November 18, 2
2008-11-18
6-Substituted pyrido-pyrimidines
Grant 7,449,581 - Chen , et al. November 11, 2
2008-11-11
Substituted pyrazolo[3,4-d]pyrimadines and methods of using the same
Grant 7,435,731 - Arora , et al. October 14, 2
2008-10-14
JNK modulators
App 20080146565 - Dunn; James Patrick ;   et al.
2008-06-19
Hydroxyalkyl substituted pyrido-7-pyrimidin-7-ones
App 20080119497 - Goldstein; David Michael
2008-05-22
Benzotriazole kinase modulators
App 20080103142 - Goldstein; David Michael ;   et al.
2008-05-01
Hydroxyalkyl substituted pyrido-7-pyrimidin-7-ones
Grant 7,348,331 - Goldstein March 25, 2
2008-03-25
6-Alkoxy-pyrido-pyrimidines
Grant 7,320,987 - Goldstein , et al. January 22, 2
2008-01-22
Imidazo-substituted compounds as p38 kinase inhibitors
Grant 7,285,561 - Goldstein , et al. October 23, 2
2007-10-23
Imidazo-substituted compounds as p38 kinase inhibitors
Grant 7,285,559 - Goldstein , et al. October 23, 2
2007-10-23
Methods of inhibiting BTK and SYK protein kinases
App 20070219195 - Goldstein; David Michael ;   et al.
2007-09-20
p38 MAP kinase inhibitors and methods for using the same
App 20070203160 - Arora; Nidhi ;   et al.
2007-08-30
Substituted quinazoline compounds useful as p38 kinase inhibitors
App 20070167471 - Dunn; James Patrick ;   et al.
2007-07-19
6-Alkoxy-pyrido-pyrimidines
App 20070167484 - Goldstein; David Michael ;   et al.
2007-07-19
Substituted quinazoline compounds useful as p38 kinase inhibitors
Grant 7,238,698 - Dunn , et al. July 3, 2
2007-07-03
Substituted 7-aza-quinazoline compounds useful as p38 kinase inhibitors
App 20070135459 - Dewdney; Nolan James ;   et al.
2007-06-14
6-Substituted pyrido-pyrimidines
App 20070135458 - Chen; Jian Jeffrey ;   et al.
2007-06-14
6-alkoxy-pyrido-pyrimidines
Grant 7,196,097 - Goldstein , et al. March 27, 2
2007-03-27
Substituted 7-azaquinazoline compounds useful as p38 kinase inhibitors
Grant 7,189,731 - Dewdney , et al. March 13, 2
2007-03-13
6-substituted pyrido-pyrimidines
Grant 7,169,794 - Chen , et al. January 30, 2
2007-01-30
6-alkoxy-pyrido-pyrimidines
App 20060276646 - Goldstein; David Michael ;   et al.
2006-12-07
Imidazo-substituted compounds as P38 kinase inhibitors
App 20060252784 - Goldstein; David Michael ;   et al.
2006-11-09
6-alkoxy-pyrido-pyrimidines
Grant 7,105,525 - Goldstein , et al. September 12, 2
2006-09-12
Imidazo-substituted compounds as p38 kinase inhibitors
Grant 7,081,462 - Goldstein , et al. July 25, 2
2006-07-25
Pyrazole derivatives-p38 MAP kinase inhibitors
Grant 6,979,693 - Goldstein , et al. December 27, 2
2005-12-27
6-alkoxy-pyrido-pyridine
Grant 6,965,030 - Goldstein , et al. November 15, 2
2005-11-15
Indazole derivatives and methods for using the same
App 20050215595 - Arora, Nidhi ;   et al.
2005-09-29
Imidazo-substituted compounds as p38 kinase inhibitors
Grant 6,949,560 - Goldstein , et al. September 27, 2
2005-09-27
6-Alkoxy-pyrido-pyrimidines
App 20050203300 - Goldstein, David Michael ;   et al.
2005-09-15
Heteroaryl-fused pyrazolo derivatives and methods for using the same
App 20050203091 - Arora, Nidhi ;   et al.
2005-09-15
Fused-pyrazolo pyrimidine and pyrazolo pyrimidinone derivatives and methods for using the same
App 20050197340 - Arora, Nidhi ;   et al.
2005-09-08
Imidazo-substituted compounds as p38 kinase inhibitors
App 20050197352 - Goldstein, David Michael ;   et al.
2005-09-08
Hydroxyalkyl substituted pyrido-7-pyrimidin-7-ones
App 20050107408 - Goldstein, David Michael
2005-05-19
Methods of treating p38 kinase-mediated disorders with pyrido[2,3-d]pyrimidin-7-one compounds
Grant 6,861,423 - Chen , et al. March 1, 2
2005-03-01
Substituted quinazoline compounds useful as P38 kinase inhibitors
App 20040209904 - Dunn, James Patrick ;   et al.
2004-10-21
Substituted 7-azaquinazoline compounds useful as p38 kinase inhibitors
App 20040209903 - Dewdney, Nolan James ;   et al.
2004-10-21
7-oxo-pyridopyrimidines (II)
App 20040192709 - Arzeno, Humberto Bartolome ;   et al.
2004-09-30
7-oxo-pyridopyrimidines (II)
Grant 6,753,427 - Arzeno , et al. June 22, 2
2004-06-22
6-Substituted pyrido-pyrimidines
App 20040116698 - Chen, Jian Jeffrey ;   et al.
2004-06-17
6-alkoxy-pyrido-pyrimidines
App 20040038999 - Goldstein, David Michael ;   et al.
2004-02-26
6-substituted pyrido-pyrimidines
Grant 6,696,566 - Chen , et al. February 24, 2
2004-02-24
Aminopyrrole compounds
Grant 6,696,471 - Goldstein , et al. February 24, 2
2004-02-24
Imidazo-substituted compounds as p38 kinase inhibitors
App 20030232847 - Goldstein, David Michael ;   et al.
2003-12-18
Alkylamino-substituted bicyclic nitrogen heterocycles
Grant 6,642,241 - Dunn , et al. November 4, 2
2003-11-04
p38 map kinase inhibitors
Grant 6,630,485 - Cheng , et al. October 7, 2
2003-10-07
6-Substituted pyrido-pyrimidines
App 20030171584 - Chen, Jian Jeffrey ;   et al.
2003-09-11
7-oxo-pyridopyrimidines (I)
App 20030153586 - Chen, Jian Jeffrey ;   et al.
2003-08-14
7-oxo-pyridopyrimidines (II)
App 20030144307 - Arzeno, Humberto Bartolome ;   et al.
2003-07-31
p38 MAP kinase inhibitors
App 20030139462 - Cheng, Soan ;   et al.
2003-07-24
Aminopyrrole compounds
App 20030130319 - Goldstein, David Michael ;   et al.
2003-07-10
7-oxo-pyridopyrimidines (II)
Grant 6,518,276 - Arzeno , et al. February 11, 2
2003-02-11
Pyrazole derivatives - p38 MAP kinase inhibitors
App 20030018051 - Goldstein, David Michael ;   et al.
2003-01-23
7-oxo-pyridopyrimidines (I)
Grant 6,506,749 - Chen , et al. January 14, 2
2003-01-14
p38 MAP kinase inhibitors
Grant 6,479,507 - Cheng , et al. November 12, 2
2002-11-12
Pyrazole derivatives - p38 MAP kinase inhibitors
App 20020156114 - Goldstein, David Michael ;   et al.
2002-10-24
7-oxo-pyridopyrimidines (I)
App 20020137756 - Chen, Jian Jeffrey ;   et al.
2002-09-26
Heteroalkylamino-substituted bicyclic nitrogen heterocycles
Grant 6,451,804 - Dunn , et al. September 17, 2
2002-09-17
Pyrazole derivatives P38 MAP kinase inhibitors
Grant 6,444,696 - Goldstein , et al. September 3, 2
2002-09-03
Pyrazole derivatives P38 MAP kinase inhibitors
App 20020103245 - Goldstein, David Michael ;   et al.
2002-08-01
7-oxo-pyridopyrimidines (II)
App 20020055513 - Arzeno, Humberto Bartolome ;   et al.
2002-05-09
p38 map kinase inhibitors
App 20020013354 - Cheng, Soan ;   et al.
2002-01-31
p38 MAP kinase inhibitors
App 20010044538 - Cheng, Soan ;   et al.
2001-11-22
Pyrazole derivatives P-38 MAP kinase inhibitors
Grant 6,316,466 - Goldstein , et al. November 13, 2
2001-11-13

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed